NYSE-Listed & China Property Group Xinyuan Real Estate United States Subsidiary Hudson 888 Owner LLC Filed for Chapter 11 Bankruptcy, Estimated Liabilities & Assets Between $100 Million to $500 Million
12th January 2024 | Hong Kong
NYSE-listed & China property group Xinyuan Real Estate United States subsidiary Hudson 888 Owner LLC has filed for Chapter 11 Bankruptcy, with estimated liabilities & assets between $100 million to $500 million. Hudson 888 Owner LLC business is listed as single-asset real estate, and owns Bloom on Forty-Fifth Condominium, a 92-unit condo building on 10th Avenue (W44/45th Street) with anchor tenant Target (United States retail giant). Xinyuan Real Estate is founded by Yong Zhang in 1997. Xinyuan Real Estate Co. is an NYSE-listed real estate developer and property manager primarily in China and recently in other countries. In China, the Company develops and manages large scale, high quality real estate projects in over ten tier one and tier two cities, including Beijing, Shanghai, Zhengzhou, Jinan, Xi’an and Suzhou, among others. Xinyuan was one of the first Chinese real estate developers to enter the U.S. market and over the past few years has been active in real estate development in New York.
“ NYSE-Listed & China Property Group Xinyuan Real Estate United States Subsidiary Hudson 888 Owner LLC Filed for Chapter 11 Bankruptcy, Estimated Liabilities & Assets Between $100 Million to $500 Million “
NYSE-Listed & China Property Group Xinyuan Real Estate United States Subsidiary Hudson 888 Owner LLC Filed for Chapter 11 Bankruptcy
Yong Zhang, CEO, Chairman and Executive Director
Yong Zhang founded the Company in 1997 and is the chairman of the board of directors and, through September 2013, he also served as the Company’s chief executive officer. Mr. Zhang has more than 20 years of working experience in the real estate industry. Prior to founding the Company, he worked at several construction and property development companies, including Zhengzhou City Construction and Development Inc. and China Antai Real Estate Development Inc. Mr. Zhang is also the vice chairman of Henan Real Estate Association, a member of China Democratic National Construction Association and a deputy to the 12th People’s Congress of Henan Province in China. Mr. Zhang received a Ph.D. in finance from Renmin University of China in 2014, an executive master’s degree in business administration from Tsinghua University in 2005 and a bachelor’s degree in civil engineering from Henan Zhongzhou University in 1985.
Xinyuan Real Estate
Xinyuan Real Estate Co., Ltd. (“Xinyuan”) is an NYSE-listed real estate developer and property manager primarily in China and recently in other countries. In China, the Company develops and manages large scale, high quality real estate projects in over ten tier one and tier two cities, including Beijing, Shanghai, Zhengzhou, Jinan, Xi’an and Suzhou, among others. Xinyuan was one of the first Chinese real estate developers to enter the U.S. market and over the past few years has been active in real estate development in New York. The Company aims to provide comfortable and convenient real estate related products and services to middle-class consumers.
Sign Up / Register
Caproasia Users
- Manage $20 million to $3 billion of assets
- Invest $3 million to $300 million
- Advise institutions, billionaires, UHNWs & HNWs
Caproasia Platforms | 11,000 Investors & Advisors
- Caproasia.com
- Caproasia Access
- Caproasia Events
- The Financial Centre | Find Services
- Membership
- Family Office Circle
- Professional Investor Circle
- Investor Relations Network
Monthly Roundtable & Networking
Family Office Programs
The 2024 Investment Day
- March 2024 - Hong Kong
- March 2024 - Singapore
- June 2024 - Hong Kong
- June 2024 - Singapore
- Sept 2024 - Hong Kong
- Sept 2024 - Singapore
- Visit: The Investment Day | Register: Click here
Caproasia Summits
- The Investment Summit
- The Private Wealth Summit
- The Family Office Summit
- The CEO & Entrepreneur Summit
- The Capital Markets Summit
- The ESG / Sustainable Investment Summit
